Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / American Depositary Shares, each representing 1 Ordinary Shares
-
Shares outstanding
-
100M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
7.05M
-
Shares change
-
+174K
-
Total reported value, excl. options
-
$219M
-
Value change
-
+$7.78M
-
Number of buys
-
28
-
Number of sells
-
-22
-
Price
-
$31.03
Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q4 2015
58 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q4 2015.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.05M shares
of 100M outstanding shares and own 7.02% of the company stock.
Largest 10 shareholders include FMR LLC (3.51M shares), Cormorant Asset Management, LLC (469K shares), ORBIMED ADVISORS LLC (350K shares), JPMORGAN CHASE & CO (300K shares), LAZARD ASSET MANAGEMENT LLC (262K shares), FRANKLIN RESOURCES INC (244K shares), Artal Group S.A. (210K shares), Clough Capital Partners L P (208K shares), Tekla Capital Management LLC (207K shares), and MILLENNIUM MANAGEMENT LLC (187K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.